Recent pharmacovigilance research has identified elevated reporting odds ratios for hair loss with semaglutide (2.46) and tirzepatide (1.73), suggesting a real association between these medications and increased shedding
The global GLP-1 Weight Loss Drug Market encompasses glucagon-like peptide-1 receptor agonists, dual GIP/GLP-1 agonists, and emerging triple-receptor agonists approved or in development for chronic weight management, type 2 diabetes remission, and metabolic disease intervention
4E), whereas SSTR-5 mRNA expression in the pituitary gland was not different between two groups (Fig
DISCOUNT PACKAGES AVAILABLE 10% discount available for each additional area booked up to 30% off
MEET THE EXPERT Dr Paula Diab is a diabetologist at Atrium Lifestyle Centre and is an extra-ordinary lecturer, Dept of Family Medicine, University of Pretoria
[20] Some evidence suggests bitter foods such as rocket, radicchio, and dark leafy greens may activate bitter taste receptors in the gut that could trigger GLP-1 release, though human studies are limited